Heidelberg Pharma, a drug development company, provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. It offers services, such as explorative pharmacology, drug metabolism and pharmacokinetics analysis, and molecular biology in the fields of oncology or inflammatory/autoimmune diseases. The Company is focused on oncology and is the first company to develop the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate technology platform and to advance the biological mode of action of the toxin as a novel therapeutic principle.
Market capitalization (21-Oct-2020)
Closing stock price (21-Oct-2020)
Heidelberg Pharma has 115 Twitter Followers. The number of followers has increased 0.2% month over month and increased 0.9% quarter over quarter
When was Heidelberg Pharma founded?
Heidelberg Pharma was founded in 1997.
Who are Heidelberg Pharma key executives?
Heidelberg Pharma's key executives are Jan Schmidt-Brand and Christof Hettich.
How many employees does Heidelberg Pharma have?
Heidelberg Pharma has 60 employees.
Who are Heidelberg Pharma competitors?
Competitors of Heidelberg Pharma include APEIRON Biologics, Captor Therapeutics and Taiho Pharmaceutical.
Where is Heidelberg Pharma headquarters?
Heidelberg Pharma headquarters is located at Gregor-Mendel-Straße 22, Ladenburg.
Where are Heidelberg Pharma offices?
Heidelberg Pharma has an office in Ladenburg.
How many offices does Heidelberg Pharma have?
Heidelberg Pharma has 2 offices.
Receive alerts for 300+ data fields across thousands of companies